Loading…
Loading…
Home › All recalls › Prescription medicine
Category
Prescription drugs recalled for contamination, potency or labelling.
Or try another category
1,991 recalls · newest first
Failed Dissolution Specifications
Failed Dissolution Specifications
Failed Dissolution Specifications
CGMP Deviations: Market complaints received for gritty texture (grainy)
CGMP Deviations
Subpotent: During long term stability testing of Levothyroxine Sodium Tablets USP for 88 mcg, the assay content was observed below the approved…
Subpotent Drug: Testing revealed there was no oxytocin in the IV bag.
Failed Dissolution Specifications.
Failed Tablet/Capsule Specifications
Chemical Contamination: This recall has been initiated due to elevated levels of benzene that was discovered during post consume awareness with…
Chemical Contamination: This recall has been initiated due to elevated levels of benzene that was discovered during post consume awareness with…
CGMP Deviations: Presence of N-Nitroso Desmethyl Chlorpromazine above the recommended intake limit
CGMP Deviations: Presence of N-Nitroso Desmethyl Chlorpromazine above the recommended intake limit
Chemical Contamination: This recall has been initiated due to elevated levels of benzene that was discovered during post consume awareness with…
Chemical Contamination: This recall has been initiated due to elevated levels of benzene that was discovered during post consume awareness with…
Chemical Contamination: This recall has been initiated due to elevated levels of benzene that was discovered during post consume awareness with…
CGMP Deviations: Presence of N-Nitroso Desmethyl Chlorpromazine above the recommended intake limit
CGMP Deviations: Presence of N-Nitroso Desmethyl Chlorpromazine above the recommended intake limit
Tablet/Capsules Imprinted with Wrong ID
CGMP Deviations: Presence of N-Nitroso Desmethyl Chlorpromazine above the recommended intake limit